Workflow
Wonders Information(300168)
icon
Search documents
万达信息(300168) - 万达信息2025年半年度非经营性资金占用及其他关联资金往来情况汇总表
2025-08-27 12:37
| 其它关联资 | | 往来方与上 | 上市公司 | 2025年期 | 2025年半年度往 | 2025年半年 | 2025年半年 | 2025年半年 | 往来形 | 往来性质 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | | 金往来 | 资金往来方名称 | 市公司的关 | 核算的会 | 初往来资 | 来累计发生金额 | 度往来资金 | 度偿还累计 | 度期末往来 | 成原因 | (经营性往来、 | | | | 联关系 | 计科目 | 金余额 | (不含利息) | 的利息(如有) | 发生金额 | 资金余额 | | 非经营性往来) | | | 上海褒发信息科技有限公司 公司 | 子公司 | 其他应收款 | 40.46 | | - | - | | 40.46 代垫款项 | 非经营性往来 | | | 深圳市万达信息有限公司 | 子公司 | 其他应收款 | 3,250.07 | 16.20 | | - | | 3,266.27 代垫款项 | 非经营性往来 | | | 上海爱递吉供应链管理服务有限 | 子公司 | 其他应收款 ...
万达信息(300168) - 关于拟签订《公有云服务实施框架项目采购合同》暨关联交易的公告
2025-08-27 12:37
万达信息股份有限公司 证券代码:300168 证券简称:万达信息 公告编号:2025-043 关于拟签订《公有云服务实施框架项目采购合同》 暨关联交易的公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚假 记载、误导性陈述或重大遗漏。 万达信息股份有限公司(以下简称"公司")于 2025 年 8 月 27 日召开第八 届董事会第十八次会议及第八届监事会第十三次会议,审议通过了《关于拟签订 <公有云服务实施框架项目采购合同>暨关联交易的议案》,关联董事阮琦先生、 钱维章先生、周莉莎女士及关联监事肖晗先生回避表决,现将相关事项公告如下: 一、关联交易概述 公司拟与中国人寿财产保险股份有限公司(以下简称"国寿财产险公司") 签订《公有云服务实施框架项目采购合同》,该合同总金额以实际发生服务为准, 合同项下国寿财产险公司向公司支付的款项总额不超过 1000 万元。 中国人寿保险股份有限公司持有公司 20.36%股份,为公司第一大股东,其 控股股东为中国人寿保险(集团)公司。国寿财产险公司为中国人寿保险(集团) 公司的控股子公司。根据《深圳证券交易所创业板股票上市规则(2025 年修订)》 的相关规 ...
万达信息(300168) - 监事会决议公告
2025-08-27 12:32
证券代码:300168 证券简称:万达信息 公告编号:2025-041 万达信息股份有限公司 第八届监事会第十三次会议决议公告 本公司及监事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、监事会会议召开情况 万达信息股份有限公司(以下简称"公司")第八届监事会第十三次会议于 2025 年 8 月 22 日以邮件方式发出通知,于 2025 年 8 月 27 日以通讯表决方式 召开。本次会议由监事会主席肖晗召集并主持,会议应出席监事 5 人,实际出 席 5 人。本次会议的召集召开符合《公司法》《公司章程》及有关法律法规的规 定。 二、监事会会议审议情况 (一)审议通过了《关于<2025 年半年度报告>全文及其摘要的议案》; 经核查,监事会认为,董事会编制和审核公司《2025 年半年度报告》的程 序符合法律、行政法规和中国证监会的规定,报告内容真实、准确、完整地反 映了公司的实际情况,不存在任何虚假记载、误导性陈述或者重大遗漏,同意 《2025 年半年度报告》全文及其摘要在中国证监会指定的信息披露网站披露。 1 经核查,监事会认为,公司 2025 年半年度募集资金存放、管理 ...
万达信息(300168) - 董事会决议公告
2025-08-27 12:31
第八届董事会第十八次会议决议公告 本公司及董事会全体成员保证信息披露的内容真实、准确、完整,没有虚 假记载、误导性陈述或重大遗漏。 一、董事会会议召开情况 万达信息股份有限公司(以下简称"公司")第八届董事会第十八次会议于 2025 年 8 月 22 日以邮件方式发出通知,于 2025 年 8 月 27 日以通讯表决方式 召开。本次会议由董事长阮琦召集并主持,会议应出席董事 9 人,实际出席 9 人。本次会议的召集召开符合《公司法》《公司章程》及有关法律法规的规定。 二、董事会会议审议情况 (一)审议通过了《关于<2025年半年度报告>全文及其摘要的议案》; 证券代码:300168 证券简称:万达信息 公告编号:2025-040 万达信息股份有限公司 员会同意将该议案提交公司董事会审议。 本议案以 9 票同意,0 票反对,0 票弃权获得通过。 《2025年半年度募集资金存放、管理与使用情况的专项报告》以及监事会发 表的意见同日披露于中国证监会指定的信息披露网站。 (三)审议通过了《关于拟签订<公有云服务实施框架项目采购合同>暨关 联交易的议案》。 本议案已经公司第八届董事会独立董事第四次专门会议审议通过,全体 ...
万达信息:2025年上半年净亏损2.99亿元,同比收窄18.20%
Xin Lang Cai Jing· 2025-08-27 11:44
万达信息公告,2025年上半年营业收入9.33亿元,同比增长1.09%。归属于上市公司股东的净亏损2.99 亿元,同比收窄18.20%。公司计划不派发现金红利,不送红股,不以公积金转增股本。 ...
万达信息(300168) - 2025 Q2 - 季度财报
2025-08-27 11:41
Financial Performance - The company's operating revenue for the first half of 2025 was ¥932,997,061.49, representing a 1.09% increase compared to ¥922,974,705.71 in the same period last year[18]. - The net loss attributable to shareholders decreased by 18.20% to ¥299,053,614.07 from ¥365,589,137.67 year-on-year[18]. - The net cash flow from operating activities improved by 19.45%, amounting to -¥509,988,469.12 compared to -¥633,139,646.53 in the previous year[18]. - The total assets at the end of the reporting period were ¥5,879,727,386.49, a decrease of 7.27% from ¥6,340,914,631.81 at the end of the previous year[18]. - The net assets attributable to shareholders decreased by 18.21% to ¥1,341,513,696.48 from ¥1,640,219,054.42[18]. - The basic earnings per share improved by 18.20% to -¥0.2076 from -¥0.2538 year-on-year[18]. - Sales expenses decreased by 25.74% to ¥44.91 million, while management expenses decreased by 21.64% to ¥150.83 million, and financial expenses decreased by 25.58% to ¥26.09 million[97]. - Research and development investment increased by 18.66% to ¥171.24 million, compared to ¥144.31 million in the previous year[97]. - The gross profit margin for the "Smart Medical Health" segment was 26.37%, with a revenue increase of 10.84% to ¥406.83 million[99]. - The "Smart Government" segment's revenue increased by 7.16% to ¥426.57 million, with a gross profit margin of 8.81%[99]. Business Segments and Innovations - The company operates in three main sectors: smart healthcare, smart government, and smart finance, leveraging ICT technology for overall software solutions[25]. - The Smart Healthcare business has provided health and insurance services to over 600 million people across more than 1,000 districts and counties in over 30 provinces, autonomous regions, and municipalities in China[26]. - The Smart Medical Insurance/Pharmaceuticals segment has successfully implemented AI fraud detection and auditing systems in Shanghai, contributing to the city's three-year action plan for medical AI[29]. - The Smart Medical segment has made significant advancements in hospital information systems, enhancing patient experience through integrated services and efficient management[30]. - The company is actively developing AI applications in healthcare, including clinical decision support and patient management systems, to enhance operational efficiency[33]. - The company has established a comprehensive smart hospital application ecosystem, integrating healthcare management and patient services across various medical institutions[33]. - The company aims to strengthen its market leadership by expanding its product offerings and enhancing its regional sales teams[31]. - The company has established a comprehensive service system in the smart governance sector, integrating "data resources + industry models + application scenarios" to support nationwide government services and urban governance[35]. - The company has successfully implemented the "One Network for All" governance service model in Shanghai and expanded its application to cities like Tianjin, Shandong, and Liaoning, setting a benchmark for nationwide promotion[36]. - The company has developed a digital system for urban governance that includes monitoring, risk warning, event handling, and comprehensive law enforcement, focusing on enhancing digital, intelligent, and integrated capabilities[38]. Research and Development - The company is focusing on AI technology applications across its products, enhancing R&D efficiency and product maturity through low-code platforms and automated testing[85]. - The company has accumulated deep expertise in standardization, participating in over 20 national and municipal standardization committees and leading the development of more than 90 national and industry standards in various fields including IT services and artificial intelligence[75]. - The company has hosted and participated in 3 major national technology projects and over 10 key national R&D plans, enhancing its product capabilities in areas such as smart cities and big data[76]. - The company is focusing on continuous R&D and innovation to maintain its competitive edge in the face of increasing industry competition driven by technologies such as AI, big data, and IoT[134]. - The company is adjusting its R&D strategy to align with national strategic directions, focusing on AI, big data, and information security[117]. Corporate Governance and Investor Relations - The company does not plan to distribute cash dividends or issue bonus shares for this reporting period[5]. - The company maintains a profit distribution policy that emphasizes stable and continuous returns to investors, with a minimum cash distribution of 10% of the annual distributable profit[154]. - The company has committed to ensuring that cash dividends over the last three years do not fall below 30% of the average annual distributable profit[154]. - The company has established a robust investor relations management framework, enhancing communication with investors through multiple channels[150]. - The company is focused on maintaining a strong corporate governance structure to protect shareholder interests and enhance market credibility[150]. - The company held 2 shareholder meetings and 5 board meetings during the reporting period, emphasizing its commitment to corporate governance and shareholder interests[150]. Future Plans and Projects - The company plans to optimize the "Future Public Health Digital Management Project" to enhance infectious disease monitoring and emergency command systems[116]. - The "Medical Operation and IoT Management Platform Innovation Project" aims to strengthen R&D for large and medium-sized medical institutions[116]. - The company is expected to leverage AI, big data, and secure controllable technology to facilitate digital transformation in government services[116]. - The company aims to achieve a revenue of 12,146 million from its citizen cloud open service platform by 2026, targeting a user base of 15,100[121]. - The company is investing in future community operation services, with a projected revenue of 29,593 million by 2026 and a user target of 2,579[121]. Legal and Compliance - The company reported a total of 9,275.93 million yuan involved in litigation as a plaintiff, which did not meet the threshold for significant litigation disclosure[160]. - The company has 11,521.50 million yuan in arbitration cases as a plaintiff, which also did not meet the threshold for significant litigation disclosure[161]. - The company has no penalties or rectification measures during the reporting period[162]. - The company engaged in related party transactions, including purchasing commercial insurance from China Life Group totaling 362.97 million yuan[163]. - The company also purchased commercial insurance from Harmony Health totaling 98.00 million yuan[163].
MLOps概念板块领涨,上涨3.52%
Di Yi Cai Jing· 2025-08-27 05:16
Group 1 - The MLOps sector leads the market with a rise of 3.52% [1] - Qiming Information increased by 10.02% [1] - Transsion Holdings rose by 5.0% [1] - Xinghuan Technology saw an increase of 4.85% [1] - Wanda Information experienced a rise of over 2% [1]
万达信息(300168)8月19日主力资金净流出2162.35万元
Sou Hu Cai Jing· 2025-08-19 17:34
Group 1 - The core viewpoint of the news is that Wanda Information (300168) has shown a decline in stock price and a significant outflow of funds, despite reporting strong revenue and profit growth in its latest quarterly earnings [1][3] - As of August 19, 2025, Wanda Information's stock closed at 8.15 yuan, down 0.97%, with a trading volume of 283,300 hands and a transaction amount of 232 million yuan [1] - The company reported total revenue of 464 million yuan for the first quarter of 2025, representing a year-on-year growth of 32.61%, and a net profit attributable to shareholders of 151.86 million yuan, up 28.27% year-on-year [1] Group 2 - The company has a liquidity ratio of 0.763 and a quick ratio of 0.588, indicating its short-term financial health [1] - Wanda Information has a debt-to-asset ratio of 75.52%, suggesting a high level of leverage [1] - The company has made investments in 63 enterprises and participated in 5,000 bidding projects, showcasing its active engagement in the market [2]
万达信息:公司无应披露而未披露的信息
Zheng Quan Ri Bao· 2025-08-18 11:12
(文章来源:证券日报) 证券日报网讯万达信息8月18日在互动平台回答投资者提问时表示,公司无应披露而未披露的信息。 ...
短线防风险 192只个股短期均线现死叉
证券时报·数据宝统计,截至下午收盘,上证综指3666.44点,涨跌幅为-0.46%,A股总成交额为23062.83 亿元。到目前为止,今日有192只A股的5日均线主动下穿10日均线,其中万达信息、联合化学、登云股 份等个股的5日均线较10日均线距离最大,分别达-1.22%、-1.15%、-1.06%。(数据宝) 部分5日、10日均线死叉个股 | 代码 | 简称 | 今日涨跌 | 今日换手 | 5日均线 | 10日均线 | 5日较10日均线 | 最新价 | 较10日均线乖 | | --- | --- | --- | --- | --- | --- | --- | --- | --- | | | | (%) | 率(%) | (元) | (元) | 距离(%) | (元) | 离率(%) | | 300168 | 万达 | -2.38 | 2.46 | 7.96 | 8.06 | -1.22 | 7.78 | -3.43 | | | 信息 | | | | | | | | | 301209 | 联合 | -2.39 | 2.89 | 93.16 | 94.25 | -1.15 | 90.72 | -3.74 | | ...